Portugal João Rito introduces Bluebio Alliance, a Portuguese association focusing on bio-based marine resources and their sustainable utilisation. Rito’s work involves extensive collaboration across sectors, including pharmaceuticals, to promote the blue bioeconomy, and he emphasises the importance of sustainable practices in harnessing marine bioresources, such as fish, seaweed, and coral, for…
Egypt The head of the French Chamber of Commerce in Egypt, Karim Wissa, dives into the current state of the Egyptian economy, the reasons behind its healthcare boom, explains why companies are rushing in under the umbrella of the universal healthcare law, and the role of France in helping Egypt grow.…
Switzerland The SXI Bio & MedTech Index outperformed the Swiss Performance Index (SPI) by 38 percent and NASDAQ Biotech by 46 per cent between 2015 and 2020. Key listings include Kuros Biosciences, Idorsia, Polyphor, ObsEva, and IGEA Pharma Made with Visme Infographic Maker To read more about the Swiss biotech investment…
USA In a recent article for PharmaBoardroom, Objective Capital’s David Crean took a look at the state of US innovation today and its long term sustainability. See below for data on the share of US executives who see innovation as a top priority post-COVID, Global Public Equity Issuance for the Biopharmaceutical…
Singapore Singapore is home to a wide range of biopharmaceutical company headquarters, many of them regional bases, and clusters. Made with Visme Infographic Maker Singaporean pharma exports are projected to grow rapidly year-on-year up to 2024. Made with Visme Infographic Maker
Singapore Singapore is far ahead of its Asia-Pacific peers in terms of GDP per person. Made with Visme Infographic Maker Singapore was ranked Asia-Pacific’s, and indeed the world’s, most competitive country/region for 2019. Made with Visme Infographic Maker Singapore also performs well on the world digital ranking, sitting behind only the…
Switzerland In just a few years, Switzerland has fallen from first to fifth place in the Global Competitiveness Index. The country is also losing ground in various subindexes, such as that for information and communication technologies, where it ranks 15th. Other studies highlight further weaknesses. For example, Switzerland is at the…
Europe A selection of data on the Nordic pharma markets (Denmark, Finland, Iceland, Norway, and Sweden), including market value, R&D spend, production, exports and imports, employment, generics penetration, and healthcare spending based on 2020 data from the EFPIA. Sweden is the largest pharma market in the region, boasting a market…
LatAm Argentina Below we highlight recent news in the Latin America region, focusing on Argentina, Colombia and Chile. Top stories cover the fight against COVID-19, economic uncertainty in the Mercosur region, and Latin American involvement in disease research. Argentina to receive 45,000 virus detection tests as part of a bigger emergency…
India The US generics market stood at USD 69 billion in 2018 and is expected to grow to USD 86 billion by 2022. Made with Visme Infographic Maker Abbreviated New Drug Applications (ANDAs), whereby a company seeks authorisation from the US FDA for a generic copy of a previously approved…
Morocco A new IQVIA study sponsored by LEMM, the Moroccan association of multinationals looked at 3,437 references sold on the private market, which represents 75 percent of the total pharma market, and shows that eight out of ten drugs on the Moroccan market are produced locally. Made with Visme Infographic Maker…
China Biosimilars are a relatively recent development in the pharmaceutical industry, meaning market penetration is still fairly low, even in many developed markets, much less emerging markets. Prior to 2019, not a single biosimilar had been approved in China. However, a McKinsey analysis found that biosimilars could account for a growing…
See our Cookie Privacy Policy Here